Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals Inc.’s DB-OTO, an AAV-mediated gene ...
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results